Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 30:16:1612785.
doi: 10.3389/fpsyt.2025.1612785. eCollection 2025.

Misuse and diversion of stimulant medications prescribed for the treatment of ADHD: a systematic review

Jessica Forrest  1 , Winnie Chen  2   3 , Karuppiah Jagadheesan  4   5
Affiliations
Review

Misuse and diversion of stimulant medications prescribed for the treatment of ADHD: a systematic review

Jessica Forrest et al. Front Psychiatry. .

Abstract

Aim: Stimulant medications are an evidence-based treatment for ADHD. However, stimulant medications are associated with a risk of misuse and diversion. Given the paucity of research, this systematic review evaluates the prevalence of misuse and diversion of stimulant medication by those who are prescribed the medication for a diagnosis of ADHD, and explores risk factors for misuse and diversion.

Methods: This systematic review was registered with PROSPERO (CRD42023469041). A systematic search of original articles from PubMed and PsycInfo on the topic of interest over a period of 10 years (2012-2023) was conducted. Risk of bias was assessed through JBI Critical Appraisal Checklist for Prevalence Studies. A meta-analysis was conducted using JBI SUMARI software.

Results: Twelve cross sectional surveys met the inclusion criteria, with study populations ranging from 88 respondents to 10,000 respondents. Meta-analysis found an average prevalence of past year prescription stimulant medication misuse of 22.6%, past year diversion of 18.2%, and lifetime diversion of 17.9%. Risk factors for misuse included being prescribed an amphetamine-based stimulant, reporting comorbid depressive and anxiety symptoms, and believing that misuse was not associated with risks. Risk factors for diversion included exposure to peers who were misusing stimulant medication, and having surplus medication available.

Conclusion: With more than one in five people reporting misuse of their prescribed stimulant medication, and one in six diverting their prescribed stimulant medication, comprehensive risk assessment and risk mitigation strategies are needed. Further research in a variety of geographic and demographic settings is needed to develop effective risk assessment tools and targeted interventions.

Keywords: ADHD; diversion; psychotropic medications; stimulant misuse; systematic review.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Meta-analysis of prevalence: past year and lifetime diversion.
Figure 2
Figure 2
Meta-analysis of prevalence: past year diversion.
Figure 3
Figure 3
Meta-analysis of prevalence: lifetime diversion.
Figure 4
Figure 4
PRISMA flow diagram.
Figure 5
Figure 5
Meta-analysis of prevalence: past year misuse.
See this image and copyright information in PMC

References

    1. APA. American Psychiatric Association . Desk Reference to the Diagnostic Criteria from DSM-5. Arlington, VA: American Psychiatric Association; (2013).
    1. Thomas R, Sanders S, Doust J, Beller E, Glasziou P. Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Pediatrics. (2015) 135:e994–1001. doi: 10.1542/peds.2014-3482 - DOI - PubMed
    1. Song P, Zha M, Yang Q, Zhang Y, Li X, Rudan I. The prevalence of adult attention-deficit hyperactivity disorder: A global systematic review and meta-analysis. J Glob Health. (2021) 11:04009. doi: 10.7189/jogh.11.04009 - DOI - PMC - PubMed
    1. AIHW . Australian institute of health and welfare. In: Australia’s children Canberra: Australian Institute of Health and Welfare (2022). Available at: https://www.aihw.gov.au/reports/children-youth/Australias-children (Accessed January 1, 2025).
    1. ADHD Guideline Development Group . Australian evidence-based clinical practice guideline for Attention Deficit Hyperactivity Disorder. Melbourne: Australian ADHD Professionals Association; (2022).

LinkOut - more resources